Home NDC 66993-580 Dutasteride and Tamsulosin Hydrochloride
Product NDC 66993-580
11-digit product format 669930580
Labeler code 66993
Product ID 66993-580_f5fa9102-81f2-47f0-9c32-79bf584413ac
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name dutasteride and tamsulosin hydrochloride
Dosage form CAPSULE
Route ORAL
Labeler Prasco Laboratories
Application NDA022460
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2016-07-01
Marketing end 2021-01-31
Substance DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Active strength 1 mg/1; mg/1
Pharmacologic classes 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA],Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022460-001 JALYN DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE 0.5MG;0.4MG CAPSULE / ORAL AB RLD 2010-06-14
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022460-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD 2010-06-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD 2010-06-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022460-001 JALYN 0.5MG;0.4MG CAPSULE / ORAL AB RLD, RS 2010-06-14 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Jalyn DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE Waylis Therapeutics aab9a2d4-5328-40f3-986f-e7753a928bc0 2026-03-09 Warnings, Adverse reactions Exact identifier application applno (NDA): 022460 application number: NDA022460